PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 4, 2026International Journal of Surgery0 citationsOpen Access

Immune-metabolic landscape and sleeve gastrectomy outcomes

View Full Paper
JCJimin ChoiYYYeuni YuEKEun Ran Kim

Key Points

  • This research aims to understand how preoperative immune-metabolic profiles impact outcomes after sleeve gastrectomy.
  • Retrospective cohort study of adults undergoing sleeve gastrectomy from January 2021 to December 2023 with 12-month follow-up.
  • Molecular analyses included circulating cytokine profiling, plasma lipid analysis, and transcriptomic sequencing of adipose tissues.
  • Participants were divided based on immune-metabolic profiles into two groups: resilient (Group1) and dysregulated (Group2).
  • In a cohort of 45 patients, Group1 experienced 31.0% weight loss compared to 25.9% in Group2 [difference 5.1 (95% CI 1.9–8.3); P = .003].
  • Group1 improved insulin sensitivity and showed transient cytokine activation while Group2 had persistent inflammation and higher levels of long-chain lipids.
  • Subclustering of Group2 revealed varying postoperative weight-loss outcomes despite similar baseline profiles.

Abstract

Background: Sleeve gastrectomy (SG) is an effective treatment for severe obesity; however, postoperative metabolic responses vary considerably. Immune-metabolic dysregulation has been suggested as a key driver of this heterogeneity, yet the integrated effects of immune and metabolic status on surgical outcomes remain unclear. Methods: We conducted a retrospective single-center cohort study of adults undergoing SG between January 2021 and December 2023, with a 12-month postoperative follow-up. Comprehensive molecular analyses – including circulating cytokine profiling, plasma lipid analysis, and transcriptomic sequencing of subcutaneous and visceral adipose tissues – were performed. Participants were stratified into two groups based on preoperative immune-metabolic profiles defined by fasting insulin, C-reactive protein, and cytokine levels: a resilient profile (Group1) and a dysregulated profile (Group2). Results: Among 45 patients who underwent SG mean (standard deviation, SD) age, 36.7 (11.0) years; 26 (57.8%) female, nine (20.0%) were classified as Group1 and 36 (80.0%) as Group2. At 12 months, mean (SD) total weight loss was 31.0 (6.8)% in Group1 vs. 25.9 (7.1)% in Group2 difference, 5.1 (95% CI 1.9–8.3); P = .003. Group1 showed greater improvement in insulin sensitivity and transient cytokine activation, whereas Group2 exhibited persistent inflammation, elevated long-chain lipid species, and transcriptomic enrichment in lipid storage, interleukin-17 signaling, and olfactory receptor pathways. Subclustering of Group2 revealed adipose-tissue-specific heterogeneity associated with divergent postoperative weight-loss trajectories, despite similar baseline profiles. Conclusions: Preoperative immune-metabolic status was associated with postoperative metabolic recovery after SG. Integrating immune-metabolic profiling with adipose transcriptomics may help identify patients more likely to achieve favorable outcomes and guide personalized interventions to enhance metabolic recovery.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Choi et al. (2026) studied this question.

synapsesocial.com/papers/6a211689d499ed480b16f772https://doi.org/10.1097/js9.0000000000005429
Ask AI
Helpful
Bookmark
Share
View Full Paper